Insider buying · SEC Form 4

Insider Buying — Jun 16, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

4insider buys
$2.24Mbought in total
4companies
1by CEOs, CFOs and other chiefs
GPGIlargest: $995K

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
GPGIGPGI Inc.Thomas R. KnottPrincipal Executive Officer$995K85,250$11.67AddedJun 15, 2026
Form 4 ↗
Bought 85,250 shares at weighted avg $11.67; spot $14.57 (+24.9%). Second large open-market buy by Knott in 2026 (previously added 44,000 shares). Cluster-buy signal in rebranded fintech/metal-card issuer (formerly CompoSecure). Transaction dated June 11, filed June 15.
AURAurora Innovation Inc.David M. WehnerDirector$498K82,500$6.04AddedJun 15, 2026
Form 4 ↗
Bought 82,500 shares at $6.04 weighted avg ($6.03–$6.05 range); spot $6.39 (+5.8%). Wehner joined AUR board Feb 2026 (former Meta CFO/CSO). First large open-market P purchase — conviction buy in autonomous trucking. Transaction dated June 11, filed June 15.
ADSKAutodesk Inc.Janesh MoorjaniEVP & Chief Financial Officer$494K2,500$197.67AddedJun 15, 2026
Form 4 ↗
CFO bought 2,500 shares at $197.67; spot $198.60 (+0.5%). Voluntary same-day open-market purchase — rare signal for a large-cap software CFO. After buy, Moorjani directly holds 50,993 shares. Transaction and filing both June 15.
PBLSParabilis Medicines Inc.Alan Sebulsky / Apothecary Capital LLCDirector$250K12,500$20.00New stakeJun 15, 2026
Form 4 ↗
Director-linked LLC bought 12,500 shares at exactly $20.00 (IPO price); spot $25.01 (+25.1%). Parabilis Medicines (Helicon peptides / oncology) IPO'd June 2026. Purchase at IPO price right after listing; shares held indirectly, Sebulsky disclaims ownership beyond pecuniary interest. Transaction dated June 11, filed June 15.

AIThe day in insider buying

SEC Form 4 Insider Scan — June 16, 2026

Scanned the last 24 hours of EDGAR Form 4 filings (filed June 15–16, 2026). 4 qualifying buys (≥ $250K, transaction type P) totalling $2.24M.

Headline filings

  • GPGI — Thomas R. Knott (Principal Executive Officer) bought 85,250 shares ≈ $994,867 at $11.67 avg; now $14.57 (+24.9% since buy). (filing)
  • AUR — David M. Wehner (Director) bought 82,500 shares ≈ $498,300 at $6.04 avg; now $6.39 (+5.8% since buy). (filing)
  • ADSK — Janesh Moorjani (CFO) bought 2,500 shares ≈ $494,175 at $197.67 avg; now $198.60 (+0.5% since buy). (filing)
  • PBLS — Apothecary Capital LLC / Alan Sebulsky (Director) bought 12,500 shares ≈ $250,000 at $20.00 (IPO price); now $25.01 (+25.1% since buy). (filing)

Notes

Theme: Conviction buys across sectors. The largest buy — GPGI's Principal Executive Officer adding $995K — continues a 2026 cluster-buying pattern in this rebranded fintech/metal-card company (formerly CompoSecure); Knott had previously purchased 44,000 shares and is adding aggressively. Aurora Innovation director David Wehner (former Meta CFO) deployed nearly $500K just 4 months after joining the board — a meaningful statement for an autonomous trucking name still sub-$7. Autodesk's CFO bought voluntarily at market on the same day as filing, a rare same-day open-market signal in large-cap software. Parabilis Medicines' director-linked fund bought at the exact IPO price right after the June 2026 biotech IPO — PBLS is now +25% from that level, validating the timing. No single-sector theme today, but C-suite/PEO-level buyers dominate the qualifying list, and all four insiders are currently in the green.

Most-bought stocks, last 30 days

  • RSG $101M · 1 buyRepublic Services, Inc.
  • HOOD $85.5M · 5 buysRobinhood Markets, Inc.
  • WGS $78.1M · 4 buys, 2 insidersGeneDx Holdings Corp.
  • ALKT $65.9M · 2 buys, 2 insidersAlkami Technology, Inc.
  • FBIN $31.3M · 4 buysFortune Brands Innovations, Inc.
  • NCLH $27.5M · 2 buys, 2 insidersNorwegian Cruise Line Holdings Ltd.
  • NSP $23.8M · 3 buysInsperity Inc.
  • TXO $18.4M · 3 buysTXO Partners, L.P.
  • BH $14.8M · 3 buys, 3 insidersBiglari Holdings Inc.
  • ARTV $12.0M · 2 buys, 2 insidersArtiva Biotherapeutics, Inc.
  • PAR $10.5M · 1 buyPAR Technology Corp.
  • WCN $7.61M · 1 buyWaste Connections, Inc.
  • MNSO $6.90M · 1 buyMINISO Group Holding Limited
  • ONON $6.59M · 3 buys, 3 insidersOn Holding AG
  • TKO $6.00M · 3 buys, 2 insidersTKO Group Holdings, Inc.
  • UA $5.87M · 1 buyUnder Armour, Inc.
  • SLMT $5.71M · 1 buySolmate Infrastructure Public Ltd (f/k/a Brera Holdings PLC)
  • AMR $5.68M · 2 buysAlpha Metallurgical Resources, Inc.
  • STEP $5.02M · 1 buyStepStone Group Inc.
  • LODE $4.35M · 3 buys, 3 insidersComstock Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.